Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Physical fatty acid deficiency signs in children with ADHD symptoms.

Sinn N.

Prostaglandins Leukot Essent Fatty Acids. 2007 Aug;77(2):109-15. Epub 2007 Sep 6.

PMID:
17825546
2.

Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial.

Sinn N, Bryan J, Wilson C.

Prostaglandins Leukot Essent Fatty Acids. 2008 Apr-May;78(4-5):311-26. doi: 10.1016/j.plefa.2008.04.004. Epub 2008 Jun 2.

PMID:
18514501
3.
5.

The association of fatty acid deficiency symptoms (FADS) with actual essential fatty acid status in cheek cells.

Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA.

Prostaglandins Leukot Essent Fatty Acids. 2010 Jul;83(1):1-8. doi: 10.1016/j.plefa.2010.02.035. Epub 2010 Mar 31.

PMID:
20356721
7.

Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.

Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR.

Nutrition. 2012 Jun;28(6):670-7. doi: 10.1016/j.nut.2011.12.009. Epub 2012 Apr 25.

PMID:
22541055
8.

Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.

Raz R, Gabis L.

Dev Med Child Neurol. 2009 Aug;51(8):580-92. doi: 10.1111/j.1469-8749.2009.03351.x. Epub 2009 Jun 22. Review.

9.

Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).

Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21. Epub 2005 Nov 28.

PMID:
16314082
10.

[Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD].

Aben A, Danckaerts M.

Tijdschr Psychiatr. 2010;52(2):89-97. Review. Dutch.

11.

The role of fatty acids in the treatment of ADHD.

Chalon S.

Neuropharmacology. 2009 Dec;57(7-8):636-9. doi: 10.1016/j.neuropharm.2009.08.012. Epub 2009 Aug 26. Review.

PMID:
19715711
12.

The potential role of fatty acids in attention-deficit/hyperactivity disorder.

Richardson AJ, Puri BK.

Prostaglandins Leukot Essent Fatty Acids. 2000 Jul-Aug;63(1-2):79-87. Review.

PMID:
10970718
13.

Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.

Gow RV, Matsudaira T, Taylor E, Rubia K, Crawford M, Ghebremeskel K, Ibrahimovic A, Vallée-Tourangeau F, Williams LM, Sumich A.

Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):151-6. doi: 10.1016/j.plefa.2008.12.007. Epub 2009 Feb 20.

PMID:
19230637
15.

Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder.

Spahis S, Vanasse M, Bélanger SA, Ghadirian P, Grenier E, Levy E.

Prostaglandins Leukot Essent Fatty Acids. 2008 Jul-Aug;79(1-2):47-53. doi: 10.1016/j.plefa.2008.07.005. Epub 2008 Aug 30.

PMID:
18757191
16.

Childrens' learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels.

Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA.

Res Dev Disabil. 2010 May-Jun;31(3):731-42. doi: 10.1016/j.ridd.2010.01.015. Epub 2010 Feb 20.

PMID:
20172688
17.

Effects of iron supplementation on attention deficit hyperactivity disorder in children.

Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaïm M, Mouren MC, Arnulf I.

Pediatr Neurol. 2008 Jan;38(1):20-6.

PMID:
18054688
18.

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.

Johnson M, Ostlund S, Fransson G, Kadesjö B, Gillberg C.

J Atten Disord. 2009 Mar;12(5):394-401. doi: 10.1177/1087054708316261. Epub 2008 Apr 30.

PMID:
18448859
19.

Polyunsaturated fatty acid supplementation for ADHD symptoms: response to commentary.

Sinn N.

J Dev Behav Pediatr. 2007 Jun;28(3):262-3. No abstract available.

PMID:
17565297

Supplemental Content

Support Center